Unbiased Analysis of Today's Healthcare Issues
The Innovation and Value Initiative today announced that it is in the process of releasing a new model and value tool to evaluate treatments for for EGFR-positive non-small cell lung cancer (NSCLC). More details on the model (named the IVI-NSCLC model) are available here, which includes a study protocol and model timeline. Oncology is an…
That is the title of an article in Eye for Pharma which interviews me about measuring value in health care. The article highlights a number of issues related to value measurement, health policy and the healthcare marketplace. The article also describes the launch of the Innovation and Value Initiative, a broad coalition of providers, payers, patient advocates,…
Dana Goldman, Samuel Nussbaum, and Mark Linthicum have an interesting post on the Health Affairs blog about innovation, value measurement and pricing. The article mentions the new Innovation and Value Initiative, where I serve as the Director of Research. An excerpt is below. New pricing mechanisms are needed to effectively link prices to value; we…